Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Marco L. Davila"'
Publikováno v:
J Clin Invest
Chimeric antigen receptor (CAR) T cell therapy has shown considerable promise for hematologic malignancies, leading to the US Food and Drug Administration approval of two CAR T cell-based therapies for the treatment of B cell acute lymphoblastic leuk
Autor:
Brigett Brandjes, Marco L. Davila
Publikováno v:
J Clin Invest
With the approval of CD19-targeted chimeric antigen receptor (CAR) T cells for the treatment of B cell malignancies, clinicians have gained valuable insights into the power and challenges of cellular therapies. In this issue of the JCI, Maluski et al